Types segmentation classifies devices by form factor and integration level, shaping the overall market size through distinct value propositions. Wearable sensors (e.g., wrist‑band ECG, patch‑based oximeters) dominate due to patient comfort and scalability, supporting both home‑care and chronic‑disease use cases. Implantable devices (e.g., telemetry‑enabled pacemakers) occupy a smaller but high‑margin niche, primarily within ICU and specialized cardiac programs. Bedside wireless monitors bridge traditional station‑based systems with wireless data transmission, sustaining relevance in ICU and post‑acute environments. Mobile hubs and gateway platforms aggregate data from multiple sensors, enabling centralized analytics for chronic‑disease and home‑care programs. Each type contributes uniquely: wearables expand the addressable population, implantables add premium clinical value, bedside monitors preserve legacy infrastructure, and mobile hubs enhance data interoperability, together forming the market taxonomy of device types.